| MVCAX | TRVPX | MVCAX / TRVPX | |
| Total Expense Ratio | 0.97 | 0.61 | 159% |
| Annual Report Gross Expense Ratio | 0.98 | 0.61 | 161% |
| Fund Existence | 25 years | 17 years | - |
| Gain YTD | 7.715 | 15.017 | 51% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 16.8B | 1.67B | 1,007% |
| Annual Yield % from dividends | 1.16 | 1.40 | 83% |
| Returns for 1 year | 9.57 | 21.35 | 45% |
| Returns for 3 years | 21.83 | 46.87 | 47% |
| Returns for 5 years | 9.01 | 5.44 | 166% |
| Returns for 10 years | 76.09 | 4.53 | 1,680% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AGGDX | 12.83 | N/A | N/A |
| American Century Focused Global Gr R6 | |||
| TPISX | 15.76 | N/A | N/A |
| Nuveen Quant Intl Small Cap Eq Premier | |||
| CWSGX | 24.16 | N/A | N/A |
| Carillon Chartwell Small Cap Growth I | |||
| FXAIX | 264.46 | N/A | N/A |
| Fidelity 500 Index | |||
| JAGLX | 77.51 | -2.09 | -2.63% |
| Janus Henderson Global Life Sciences T | |||